Literature DB >> 2318434

Osteoporosis and skeletal fractures in chronic liver disease.

T Diamond1, D Stiel, M Lunzer, M Wilkinson, J Roche, S Posen.   

Abstract

In order to determine the prevalence and severity of hepatic osteodystrophy by non-invasive means we compared 115 consecutive ambulant patients with histologically proven chronic liver disease to 113 age and sex matched control subjects. Methods used included the assessment of fracture prevalence rates, spinal radiography, and measurements of bone mineral density in the spine and the forearm. Spinal and peripheral fractures were more prevalent in the patients than in the control subjects (p less than 0.03 and p less than 0.01 respectively). The type of the underlying liver disease did not significantly affect the fracture prevalence rates, but alcoholic patients sustained more peripheral fractures than patients with other hepatic disorders (p less than 0.05). The bone mineral densities of the spines and the forearms were significantly reduced in male patients of all age groups and in female patients aged 60 years or more (p less than 0.001 for men and p less than 0.01 for women for both measurements). The prevalence rates of spinal and forearm osteoporosis were twice as high among patients with liver disease than in control subjects regardless of the definitions used. The presence of cirrhosis and hypogonadism were major risk factors for development of both spinal (Beta coef = 0.190 and 0.176; SE = 0.079 and 0.086 respectively) and forearm osteoporosis (Beta coef = 0.20 and 0.29; SE = 0.073 and 0.80 respectively). Spinal bone density was the predominant determinant of spinal fractures (Beta coef = -0.007; SE = 0.001), while hypogonadism (Beta coef = 0.363; SE = 0.075) and cirrhosis (Beta coef = 0.185; SE = 0.068) were the major predictors of peripheral fractures. The concentrations of serum calcium and serum vitamin D metabolites and the use of corticosteroids were apparently without effect on the prevalence of skeletal fractures or bone density.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318434      PMCID: PMC1378345          DOI: 10.1136/gut.31.1.82

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  53 in total

1.  Bone changes after alcohol abuse.

Authors:  C M Schnitzler; L Solomon
Journal:  S Afr Med J       Date:  1984-11-10

2.  A postprocessing dual energy technique for vertebral CT densitometry.

Authors:  A M Laval-Jeantet; C E Cann; B Roger; P Dallant
Journal:  J Comput Assist Tomogr       Date:  1984-12       Impact factor: 1.826

3.  Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis.

Authors:  C Barbatis; P Grases; H A Shepherd; R W Chapman; J Trowell; D P Jewell; J O McGee
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

4.  Bone disease in alcohol abuse.

Authors:  D D Bikle; H K Genant; C Cann; R R Recker; B P Halloran; G J Strewler
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

5.  Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men.

Authors:  M C de Vernejoul; J Bielakoff; M Herve; J Gueris; M Hott; D Modrowski; D Kuntz; L Miravet; A Ryckewaert
Journal:  Clin Orthop Relat Res       Date:  1983-10       Impact factor: 4.176

6.  Risk factors for spinal osteoporosis in men.

Authors:  E Seeman; L J Melton; W M O'Fallon; B L Riggs
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

7.  Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.

Authors:  J A Cuthbert; C Y Pak; J E Zerwekh; K D Glass; B Combes
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

8.  Accuracy and clinical utility of simplified tests of antipyrine metabolism.

Authors:  G C Farrell; L Zaluzny
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

9.  Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment.

Authors:  S A Mobarhan; R M Russell; R R Recker; D B Posner; F L Iber; P Miller
Journal:  Hepatology       Date:  1984 Mar-Apr       Impact factor: 17.425

10.  Quantitative computed tomography for prediction of vertebral fracture risk.

Authors:  C E Cann; H K Genant; F O Kolb; B Ettinger
Journal:  Bone       Date:  1985       Impact factor: 4.398

View more
  50 in total

1.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

3.  Liver: risk of falls in cirrhosis predicted by psychometric testing.

Authors:  Roger F Butterworth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

4.  Pamidronate and osteoporosis prevention in liver transplant recipients.

Authors:  Pietra Pennisi; Andrea Trombetti; Emiliano Giostra; Gilles Mentha; René Rizzoli; Carmelo E Fiore
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

5.  Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease.

Authors:  T Diamond; R Pojer; D Stiel; A Alfrey; S Posen
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

6.  Mandibular fracture scoring system: for prediction of complications.

Authors:  D Prabhu Shankar; P Manodh; Pradeep Devadoss; Titus K Thomas
Journal:  Oral Maxillofac Surg       Date:  2012-04-28

7.  Bone disorders in experimentally induced liver disease in growing rats.

Authors:  Viktória Ferencz; Csaba Horváth; Béla Kári; János Gaál; Szilvia Mészáros; Zsuzsanna Wolf; Dalma Hegedus; Andrea Horváth; Anikó Folhoffer; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

8.  Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study.

Authors:  G Y Minuk; R Greenberg; J Uhanova; K Hawkins; W D Leslie
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

9.  Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting.

Authors:  Schalk W van der Merwe; Maria M Conradie; Robert Bond; Brenda J Olivier; Elongo Fritz; Martin Nieuwoudt; Rhena Delport; Tomas Slavik; Gert Engelbrecht; Del Kahn; Enid G Shephard; Maritha J Kotze; Nico P de Villiers; Stephen Hough
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

Review 10.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.